Recording an accurate history on COVID-19 medications for children

CCommon sense and our experience suggest that prevention is better than cure. Gone are the days of brain children with polio. Gone are the days of many children suffering from malignant meningitis. Gone are the days when it was impossible to prevent hundreds of children each year from dying of malaria. That’s the value of the drug, the more the drug.

As with many things in medicine, we need to balance the risks and benefits when dealing with all patients, especially children. When we first responded to COVID-19, we had to decide without complete knowledge. Two years of maintenance and research have given us a wealth of knowledge about COVID-19. The medical and scientific communities have provided us with clear information to accurately set the history of the risks and benefits of COVID-19 vaccines in children.

Sadly, in the US more than 1000 children die and more than 7,400 cases of children with a common condition called multisystem inflammatory syndrome in children (MISC) due to COVID- 19. We’re only learning about long-term COVID in children, most of whom haven’t been hospitalized, or may have severe fatigue, headaches, and “brain-fog,” can continue for months after COVID-19.

For people under 15 years of age, COVID-19 is the sixth leading cause of death in the US. In comparison, if a year had a very good influenza, up to 200 children would die and 20,000 hospitalized. Partly due to influenza medications, deaths due to influenza -like illness are not the top 10 causes of death among children.

It is true that children with COVID-19 do better than babies. Patients over 18 years of age were four times less likely to need hospitalization than patients over 65 years of age and 65 times less likely to die from COVID-19. However, children became ill and died from COVID-19. During the last Omicron wave more than 4.8 million children became ill and more than 30,000 were hospitalized. About 20% of children hospitalized under the new Omicron wave will need to be cared for in intensive care units. Most of these children have not been treated.

Some people believe that COVID-19 is serious, which means that cases that require hospitalization or result in death, only apply to children with medical conditions. This is a mistake. Approximately 40% of children with severe COVID-19 have no lower medical conditions. Conditions that increase a child’s risk of being hospitalized include asthma, obesity, and chronic kidney disease. Importantly, mental health problems, including anxiety and depression, were found to be associated with severe COVID-19. Recent studies show that more than half of children with pre-existing COVID-19 infections did not receive antibodies more than six months after infection, indicating that the disease was not previously safe. Therefore, from the doctor’s point of view, in order to protect children from severe COVID-19 and death, we cannot say that a child will get the vaccine but another will not.

Further evidence of COVID-19 vaccines now approved by the FDA for children reduces the risk of receiving severe COVID-19. Recent peer -reviewed studies show that these drugs are 70 to 90% effective in keeping children between 5 and 17 years of age out of the hospital if the child has two seasons. , and more research shows how to prevent more serious illness. In the US, for every 100,000 children with COVID-19, 700 to 900 are hospitalized. This means that for every 100,000 children fully enrolled, more than 500 hospitals will be covered. This will reduce pediatric deaths and the risk of MISC and long-term-COVID. Having low levels of COVID-19 in children is likely to reduce the risk of the disease spreading to classmates, teachers and family members, including those with other medical conditions. putting them on a lot of serious illness.

It is always important to balance the value of the right medication with the side effects. We now have data on about 37 million sessions of COVID-19 vaccine given to children between 5 and 17 years of age. Serious side effects, including dizziness, headache, and fever, occur in about 5 per 10,000 children. Serious side effects, such as heart attack, or myocarditis, are found in 1 in 1,000,000 vaccines. These risks are very low compared to the hospitalization risk and death for a child with COVID-19.

Interestingly, there is concern about the association between COVID-19 disease and myocarditis. Here we have a lot of information about this problem. In the highest risk group, young boys, the prevalence of myocarditis after injection was 5 per 100,000 vaccines, no deaths in people under 30 years of age and normal survival. full. In comparison, if a person under 16 years of age had COVID-19, the risk of myocarditis was 130 per 100,000. The risk of myocarditis in children is 25 times higher if you get COVID-19 compared to vaccine.

As the public plays an important role in the management and prevention of COVID-19, it is important for parents, children, and health care providers to have accurate information. For those facing a decision about whether they should enroll their child with COVID-19, consider the facts and talk with your health care provider about the risks and benefits. Consider how many children will suffer from polio, suffer from the effects of meningitis, or die of malaria, if their parents do not balance the risks and benefits. of pediatric medicine.

Must Read Stories from TIME


Contact us ma [email protected]

Related Posts

Leave a Reply

Your email address will not be published.